0000914760-16-000386.txt : 20160316 0000914760-16-000386.hdr.sgml : 20160316 20160316163706 ACCESSION NUMBER: 0000914760-16-000386 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160314 FILED AS OF DATE: 20160316 DATE AS OF CHANGE: 20160316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDBERG DAVID C CENTRAL INDEX KEY: 0001251336 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 161510132 MAIL ADDRESS: STREET 1: C/O ENZO BIOCHEM INC STREET 2: 527 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 formfour.xml X0306 4 2016-03-14 0 0000316253 ENZO BIOCHEM INC ENZ 0001251336 GOLDBERG DAVID C C/O ENZO BIOCHEM INC 527 MADISON AVE NEW YORK NY 10022 0 1 0 0 VP CorpDev IGM Enz Clin Labs Stock Option (to acquire common stock) 4.35 2016-03-14 4 A 0 18000 0 A 2017-03-15 2021-03-13 Common Stock 18000 47455 D The Reporting Person was granted 18,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, begininning March 15, 2017. /s/ David C. Goldberg 2016-03-16